Abstract
Cerebral malaria (CM), defined as the presence of P. falciparum asexual stages on peripheral blood smear in a person with coma and no other cause for encephalopathy, is estimated to affect more than 800,000 people a year and has a 15–20 % mortality rate. CM predominantly affects children <5 years of age in Africa, but in Southeast Asia it is more common in adolescents and adults. Approximately 25 % of African children with CM develop long-term cognitive impairment. The pathogenesis of cerebral malaria appears to involve several components. The primary factor in pathogenesis of CM is thought to be sequestration, a blockage of microcirculatory vessels in the brain by parasitized red blood cells, along with lesser numbers of leukocytes and platelets. Other factors that appear to be involved in pathogenesis include systemic and central nervous system (CNS) production of proinflammatory cytokines and chemokines, including tumor necrosis factor, interferon-γ, and RANTES; release of free heme during hemolysis; endothelial activation leading to blood–brain barrier breakdown; CNS nitric oxide production; and genetic polymorphisms (e.g., sickle cell trait) that alter these responses or protect in other ways from severe disease. Murine models of cerebral malaria have provided new insights into the disease, but the difference in the parasite species and the host response has limited translation of findings from murine models into human CM studies. Nonhuman primate models are closer to human disease, but are limited by cost and ethical concerns. Therapies currently being studied for adjunctive therapy in CM include arginine (a donor of nitric oxide), inhaled nitric oxide, and recombinant erythropoietin. The potential benefits and harm of each therapy require close study, as many areas of CM pathogenesis remain unclear. Further studies are required, particularly in human disease, to better understand pathogenesis so that effective adjunctive therapy for this illness can be developed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- ANG1:
-
Angiopoietin-1
- ANG2:
-
Angiopoietin-2
- BBB:
-
Blood–brain barrier
- CM:
-
Cerebral malaria
- CNS:
-
Central nervous system
- CSF:
-
Cerebral spinal fluid
- EC:
-
Endothelial cell
- ECM:
-
Experimental cerebral malaria
- EDHF:
-
Endothelium-derived hyperpolarization factor
- EPO:
-
Erythropoietin
- ET-1:
-
Endothelin-1
- G6PD:
-
Glucose-6-phosphate dehydrogenase
- GPI:
-
Glycosylphosphatidylinositol
- HO:
-
Heme oxygenase
- ICAM-1:
-
Intercellular adhesion molecule-1
- iNOS:
-
Inducible nitric oxide synthase
- LT:
-
Lymphotoxin
- MT:
-
Metallothionein
- NK:
-
Natural killer
- NO:
-
Nitric oxide
- P:
-
Plasmodium
- PfEMP-1:
-
P. falciparum erythrocyte membrane protein-1
- pRBC:
-
Parasitized red blood cell
- SNP:
-
Single nucleotide polymorphisms
- TLR:
-
Toll-like receptor
- VCAM-1:
-
Vascular cell-adhesion molecule-1
- VWF:
-
von Willebrand factor
- WHO:
-
World Health Organization
References
WHO. World malaria report 2012. Geneva, Switzerland: World Health Organization; 2012.
Murray CJ, Rosenfeld LC, Lim SS, Andrews KG, Foreman KJ, Haring D, et al. Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet. 2012;379(9814): 413–31. PubMed PMID: 22305225.
Hien TT, Day NPJ, Phu NH, Mai NTH, Chau TTH, Loc PP, et al. A controlled trial of Artemether or quinine in Vietnamese adults with severe falciparum malaria. N Engl J Med. 1996;335(2):76–83. PubMed PMID: 8649493.
WHO. Severe falciparum malaria. World Health Organization, communicable diseases cluster. Trans R Soc Trop Med Hyg. 2000;94 Suppl 1:S1–90. PubMed PMID: 11103309.
Newton CR, Krishna S. Severe falciparum malaria in children: current understanding of pathophysiology and supportive treatment. Pharmacol Ther. 1998;79(1):1–53. PubMed PMID: 9719344.
John CC, Panoskaltsis-Mortari A, Opoka RO, Park GS, Orchard PJ, Jurek AM, et al. Cerebrospinal fluid cytokine levels and cognitive impairment in cerebral malaria. Am J Trop Med Hyg. 2008;78(2):198–205. PubMed PMID: 18256412.
Idro R, Jenkins NE, Newton CR. Pathogenesis, clinical features, and neurological outcome of cerebral malaria. Lancet Neurol. 2005;4(12):827–40. PubMed PMID: 16297841.
Idro R, Kakooza-Mwesige A, Balyejjussa S, Mirembe G, Mugasha C, Tugumisirize J, et al. Severe neurological sequelae and behaviour problems after cerebral malaria in Ugandan children. BMC Res Notes. 2010;3:104. PubMed PMID: 20398391, Pubmed Central PMCID: 2861066.
Idro R, Marsh K, John CC, Newton CR. Cerebral malaria: mechanisms of brain injury and strategies for improved neurocognitive outcome. Pediatr Res. 2010;68(4):267–74. PubMed PMID: 20606600, Pubmed Central PMCID: 3056312.
Boivin MJ, Bangirana P, Byarugaba J, Opoka RO, Idro R, Jurek AM, et al. Cognitive impairment after cerebral malaria in children: a prospective study. Pediatrics. 2007;119(2):e360–6. PubMed PMID: 17224457, Pubmed Central PMCID: 2743741.
Newton CR, Warrell DA. Neurological manifestations of falciparum malaria. Ann Neurol. 1998;43(6):695–702. PubMed PMID: 9629838.
Haldar K, Murphy SC, Milner DA, Taylor TE. Malaria: mechanisms of erythrocytic infection and pathological correlates of severe disease. Annu Rev Pathol. 2007;2:217–49. PubMed PMID: 18039099.
Berendt AR, Ferguson DJ, Gardner J, Turner G, Rowe A, McCormick C, et al. Molecular mechanisms of sequestration in malaria. Parasitology. 1994;108(Suppl):S19–28. PubMed PMID: 8084651.
Patnaik JK, Das BS, Mishra SK, Mohanty S, Satpathy SK, Mohanty D. Vascular clogging, mononuclear cell margination, and enhanced vascular permeability in the pathogenesis of human cerebral malaria. Am J Trop Med Hyg. 1994;51(5):642–7. PubMed PMID: 7985757.
Grau GE, Mackenzie CD, Carr RA, Redard M, Pizzolato G, Allasia C, et al. Platelet accumulation in brain microvessels in fatal pediatric cerebral malaria. J Infect Dis. 2003;187(3):461–6. PubMed PMID: 12552430.
Ponsford MJ, Medana IM, Prapansilp P, Hien TT, Lee SJ, Dondorp AM, et al. Sequestration and microvascular congestion are associated with coma in human cerebral malaria. J Infect Dis. 2012;205(4):663–71. PubMed PMID: 22207648, Pubmed Central PMCID: 3266137.
Medana IM, Day NP, Hien TT, Mai NT, Bethell D, Phu NH, et al. Axonal injury in cerebral malaria. Am J Pathol. 2002;160(2):655–66. PubMed PMID: 11839586, Pubmed Central PMCID: 1850649.
Cooke BM, Morris-Jones S, Greenwood BM, Nash GB. Mechanisms of cytoadhesion of flowing, parasitized red blood cells from Gambian children with falciparum malaria. Am J Trop Med Hyg. 1995;53(1):29–35. PubMed PMID: 7542844.
Newbold C, Warn P, Black G, Berendt A, Craig A, Snow B, et al. Receptor-specific adhesion and clinical disease in Plasmodium falciparum. Am J Trop Med Hyg. 1997;57(4):389–98. PubMed PMID: 9347951.
Chakravorty SJ, Hughes KR, Craig AG. Host response to cytoadherence in Plasmodium falciparum. Biochem Soc Trans. 2008;36(Pt 2):221–8. PubMed PMID: 18363564.
Park GS, Ireland KF, Opoka RO, John CC. Evidence of endothelial activation in asymptomatic plasmodium falciparum parasitemia and effect of blood group on levels of von Willebrand factor in malaria. J Pediatr Infect Dis Soc. 2012;1(1):16–25.
van der Heyde HC, Nolan J, Combes V, Gramaglia I, Grau GE. A unified hypothesis for the genesis of cerebral malaria: sequestration, inflammation and hemostasis leading to microcirculatory dysfunction. Trends Parasitol. 2006;22(11):503–8. PubMed PMID: 16979941.
Handunnetti SM, David PH, Perera KL, Mendis KN. Uninfected erythrocytes form “rosettes” around Plasmodium falciparum infected erythrocytes. Am J Trop Med Hyg. 1989;40(2): 115–8. PubMed PMID: 2645800.
Pain A, Ferguson DJ, Kai O, Urban BC, Lowe B, Marsh K, et al. Platelet-mediated clumping of Plasmodium falciparum-infected erythrocytes is a common adhesive phenotype and is associated with severe malaria. Proc Natl Acad Sci U S A. 2001;98(4):1805–10. PubMed PMID: 11172032, Pubmed Central PMCID: 29338.
Chotivanich K, Sritabal J, Udomsangpetch R, Newton P, Stepniewska KA, Ruangveerayuth R, et al. Platelet-induced autoagglutination of Plasmodium falciparum-infected red blood cells and disease severity in Thailand. J Infect Dis. 2004;189(6):1052–5. PubMed PMID: 14999609.
Cooke BM, Mohandas N, Coppel RL. Malaria and the red blood cell membrane. Semin Hematol. 2004;41(2):173–88. PubMed PMID: 15071793.
Ahlqvist J. Decreased red cell deformability and vascular obstruction in falciparum malaria illustrated by a fatal case. Scand J Haematol. 1985;35(5):531–5. PubMed PMID: 3911374.
Bridges DJ, Bunn J, van Mourik JA, Grau G, Preston RJ, Molyneux M, et al. Rapid activation of endothelial cells enables Plasmodium falciparum adhesion to platelet-decorated von Willebrand factor strings. Blood. 2010;115(7):1472–4. PubMed PMID: 19897581, Pubmed Central PMCID: 2840836.
Augustin HG, Koh GY, Thurston G, Alitalo K. Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat Rev Mol Cell Biol. 2009;10(3):165–77. PubMed PMID: 19234476.
Fiedler U, Reiss Y, Scharpfenecker M, Grunow V, Koidl S, Thurston G, et al. Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat Med. 2006;12(2):235–9. PubMed PMID: 16462802.
Andresen J, Shafi NI, Bryan Jr RM. Endothelial influences on cerebrovascular tone. J Appl Physiol. 2006;100(1):318–27. PubMed PMID: 16357085.
Toure FS, Ouwe-Missi-Oukem-Boyer O, Bisvigou U, Moussa O, Rogier C, Pino P, et al. Apoptosis: a potential triggering mechanism of neurological manifestation in Plasmodium falciparum malaria. Parasite Immunol. 2008;30(1):47–51. PubMed PMID: 18086016.
Maier AG, Rug M, O’Neill MT, Brown M, Chakravorty S, Szestak T, et al. Exported proteins required for virulence and rigidity of Plasmodium falciparum-infected human erythrocytes. Cell. 2008;134(1):48–61. PubMed PMID: 18614010, Pubmed Central PMCID: 2568870.
Maier AG, Cooke BM, Cowman AF, Tilley L. Malaria parasite proteins that remodel the host erythrocyte. Nat Rev Microbiol. 2009;7(5):341–54. PubMed PMID: 19369950.
Mishra SK, Wiese L. Advances in the management of cerebral malaria in adults. Curr Opin Neurol. 2009;22(3):302–7. PubMed PMID: 19434799.
de Souza JB, Hafalla JC, Riley EM, Couper KN. Cerebral malaria: why experimental murine models are required to understand the pathogenesis of disease. Parasitology. 2010;137(5):755–72. PubMed PMID: 20028608.
Taylor TE, Fu WJ, Carr RA, Whitten RO, Mueller JS, Fosiko NG, et al. Differentiating the pathologies of cerebral malaria by postmortem parasite counts. Nat Med. 2004;10(2):143–5. PubMed PMID: 14745442.
Seydel KB, Milner Jr DA, Kamiza SB, Molyneux ME, Taylor TE. The distribution and intensity of parasite sequestration in comatose Malawian children. J Infect Dis. 2006;194(2):208–15. PubMed PMID: 16779727, Pubmed Central PMCID: 1515074.
Looareesuwan S, Wilairatana P, Krishna S, Kendall B, Vannaphan S, Viravan C, et al. Magnetic resonance imaging of the brain in patients with cerebral malaria. Clin Infect Dis. 1995;21(2):300–9. PubMed PMID: 8562735.
White NJ. Lumbar puncture in cerebral malaria. Lancet. 1991;338(8767):640–1. PubMed PMID: 1679182.
Langhorne J, Buffet P, Galinski M, Good M, Harty J, Leroy D, et al. The relevance of non-human primate and rodent malaria models for humans. Malar J. 2011;10(1):23. PubMed PMID: 21288352, Pubmed Central PMCID: 3041720.
Curfs JH, Schetters TP, Hermsen CC, Jerusalem CR, van Zon AA, Eling WM. Immunological aspects of cerebral lesions in murine malaria. Clin Exp Immunol. 1989;75(1):136–40. PubMed PMID: 2649283, Pubmed Central PMCID: 1541862.
Schofield L, Grau GE. Immunological processes in malaria pathogenesis. Nat Rev Immunol. 2005;5(9):722–35. PubMed PMID: 16138104.
Mitchell AJ, Hansen AM, Hee L, Ball HJ, Potter SM, Walker JC, et al. Early cytokine production is associated with protection from murine cerebral malaria. Infect Immun. 2005;73(9):5645–53. PubMed PMID: 16113282, Pubmed Central PMCID: 1231146.
Curfs JH, van der Meide PH, Billiau A, Meuwissen JH, Eling WM. Plasmodium berghei: recombinant interferon-gamma and the development of parasitemia and cerebral lesions in malaria-infected mice. Exp Parasitol. 1993;77(2):212–23. PubMed PMID: 8375490.
White NJ, Turner GD, Medana IM, Dondorp AM, Day NP. The murine cerebral malaria phenomenon. Trends Parasitol. 2010;26(1):11–5. PubMed PMID: 19932638, Pubmed Central PMCID: 2807032.
Engwerda C, Belnoue E, Gruner AC, Renia L. Experimental models of cerebral malaria. Curr Top Microbiol Immunol. 2005;297:103–43. PubMed PMID: 16265904.
de Souza JB, Riley EM. Cerebral malaria: the contribution of studies in animal models to our understanding of immunopathogenesis. Microbes Infect. 2002;4(3):291–300. PubMed PMID: 11909739.
Belnoue E, Kayibanda M, Vigario AM, Deschemin JC, van Rooijen N, Viguier M, et al. On the pathogenic role of brain-sequestered alphabeta CD8+ T cells in experimental cerebral malaria. J Immunol. 2002;169(11):6369–75. PubMed PMID: 12444144.
Lou J, Lucas R, Grau GE. Pathogenesis of cerebral malaria: recent experimental data and possible applications for humans. Clin Microbiol Rev. 2001;14(4):810–20. Table of contents, PubMed PMID: 11585786, Pubmed Central PMCID: 89004.
Ma N, Hunt NH, Madigan MC, Chan-Ling T. Correlation between enhanced vascular permeability, up-regulation of cellular adhesion molecules and monocyte adhesion to the endothelium in the retina during the development of fatal murine cerebral malaria. Am J Pathol. 1996;149(5):1745–62. PubMed PMID: 8909263, Pubmed Central PMCID: 1865264.
Hansen DS, Bernard NJ, Nie CQ, Schofield L. NK cells stimulate recruitment of CXCR3+ T cells to the brain during Plasmodium berghei-mediated cerebral malaria. J Immunol. 2007;178(9):5779–88. PubMed PMID: 17442962.
Belnoue E, Potter SM, Rosa DS, Mauduit M, Gruner AC, Kayibanda M, et al. Control of pathogenic CD8+ T cell migration to the brain by IFN-gamma during experimental cerebral malaria. Parasite Immunol. 2008;30(10):544–53. PubMed PMID: 18665903.
Hansen DS, Siomos MA, Buckingham L, Scalzo AA, Schofield L. Regulation of murine cerebral malaria pathogenesis by CD1d-restricted NKT cells and the natural killer complex. Immunity. 2003;18(3):391–402. PubMed PMID: 12648456.
Renia L, Potter SM, Mauduit M, Rosa DS, Kayibanda M, Deschemin JC, et al. Pathogenic T cells in cerebral malaria. Int J Parasitol. 2006;36(5):547–54. PubMed PMID: 16600241.
Yanez DM, Manning DD, Cooley AJ, Weidanz WP, van der Heyde HC. Participation of lymphocyte subpopulations in the pathogenesis of experimental murine cerebral malaria. J Immunol. 1996;157(4):1620–4. PubMed PMID: 8759747.
Yanez DM, Batchelder J, van der Heyde HC, Manning DD, Weidanz WP. Gamma delta T-cell function in pathogenesis of cerebral malaria in mice infected with Plasmodium berghei ANKA. Infect Immun. 1999;67(1):446–8. PubMed PMID: 9864254, Pubmed Central PMCID: 96335.
Grau GE, Heremans H, Piguet PF, Pointaire P, Lambert PH, Billiau A, et al. Monoclonal antibody against interferon gamma can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor. Proc Natl Acad Sci U S A. 1989; 86(14):5572–4. PubMed PMID: 2501793, Pubmed Central PMCID: 297664.
Hanum PS, Hayano M, Kojima S. Cytokine and chemokine responses in a cerebral malaria-susceptible or -resistant strain of mice to Plasmodium berghei ANKA infection: early chemokine expression in the brain. Int Immunol. 2003;15(5):633–40. PubMed PMID: 12697663.
Engwerda CR, Mynott TL, Sawhney S, De Souza JB, Bickle QD, Kaye PM. Locally up-regulated lymphotoxin alpha, not systemic tumor necrosis factor alpha, is the principle mediator of murine cerebral malaria. J Exp Med. 2002;195(10):1371–7. PubMed PMID: 12021316, Pubmed Central PMCID: 2193758.
Lucas R, Lou JN, Juillard P, Moore M, Bluethmann H, Grau GE. Respective role of TNF receptors in the development of experimental cerebral malaria. J Neuroimmunol. 1997;72(2):143–8. PubMed PMID: 9042106.
Grau GE, Fajardo LF, Piguet PF, Allet B, Lambert PH, Vassalli P. Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. Science. 1987;237(4819):1210–2. PubMed PMID: 3306918.
Wiese L, Kurtzhals JA, Penkowa M. Neuronal apoptosis, metallothionein expression and proinflammatory responses during cerebral malaria in mice. Exp Neurol. 2006;200(1):216–26. PubMed PMID: 16624296.
Desruisseaux MS, Gulinello M, Smith DN, Lee SC, Tsuji M, Weiss LM, et al. Cognitive dysfunction in mice infected with Plasmodium berghei strain ANKA. J Infect Dis. 2008;197(11):1621–7. PubMed PMID: 18419550, Pubmed Central PMCID: 2692506.
Migasena P, Maegraith BG. The movement of the dye (disulphine blue) from blood into brain tissue examined by dye method in normal and Plasmodium berghei infected mice. Med J Malaya. 1968;22(3):252. PubMed PMID: 4234391.
Ma N, Madigan MC, Chan-Ling T, Hunt NH. Compromised blood-nerve barrier, astrogliosis, and myelin disruption in optic nerves during fatal murine cerebral malaria. Glia. 1997;19(2):135–51. PubMed PMID: 9034830.
Thumwood CM, Hunt NH, Clark IA, Cowden WB. Breakdown of the blood-brain barrier in murine cerebral malaria. Parasitology. 1988;96(Pt 3):579–89. PubMed PMID: 2457201.
van der Heyde HC, Bauer P, Sun G, Chang WL, Yin L, Fuseler J, et al. Assessing vascular permeability during experimental cerebral malaria by a radiolabeled monoclonal antibody technique. Infect Immun. 2001;69(5):3460–5. PubMed PMID: 11292776, Pubmed Central PMCID: 98312.
Ampawong S, Combes V, Hunt NH, Radford J, Chan-Ling T, Pongponratn E, et al. Quantitation of brain edema and localisation of aquaporin 4 expression in relation to susceptibility to experimental cerebral malaria. Int J Clin Exp Pathol. 2011;4(6):566–74. PubMed PMID: 21904632, Pubmed Central PMCID: 3160608.
Penet MF, Viola A, Confort-Gouny S, Le Fur Y, Duhamel G, Kober F, et al. Imaging experimental cerebral malaria in vivo: significant role of ischemic brain edema. J Neurosci. 2005;25(32):7352–8. PubMed PMID: 16093385.
Szklarczyk A, Stins M, Milward EA, Ryu H, Fitzsimmons C, Sullivan D, et al. Glial activation and matrix metalloproteinase release in cerebral malaria. J Neurovirol. 2007;13(1):2–10. PubMed PMID: 17454443.
Lakhan SE, Kirchgessner A, Tepper D, Leonard A. Matrix metalloproteinases and blood-brain barrier disruption in acute ischemic stroke. Front Neurol. 2013;4:32. PubMed PMID: 23565108, Pubmed Central PMCID: 3615191.
Rest JR. Cerebral malaria in inbred mice. I. A new model and its pathology. Trans R Soc Trop Med Hyg. 1982;76(3):410–5. PubMed PMID: 7051459.
Riley EM, Couper KN, Helmby H, Hafalla JC, de Souza JB, Langhorne J, et al. Neuropathogenesis of human and murine malaria. Trends Parasitol. 2010;26(6):277–8. PubMed PMID: 20338809.
Baptista FG, Pamplona A, Pena AC, Mota MM, Pied S, Vigario AM. Accumulation of Plasmodium berghei-infected red blood cells in the brain is crucial for the development of cerebral malaria in mice. Infect Immun. 2010;78(9):4033–9. PubMed PMID: 20605973, Pubmed Central PMCID: 2937458.
Franke-Fayard B, Janse CJ, Cunha-Rodrigues M, Ramesar J, Buscher P, Que I, et al. Murine malaria parasite sequestration: CD36 is the major receptor, but cerebral pathology is unlinked to sequestration. Proc Natl Acad Sci U S A. 2005;102(32):11468–73. PubMed PMID: 16051702, Pubmed Central PMCID: 1183563.
Amante FH, Haque A, Stanley AC, Rivera Fde L, Randall LM, Wilson YA, et al. Immune-mediated mechanisms of parasite tissue sequestration during experimental cerebral malaria. J Immunol. 2010;185(6):3632–42. PubMed PMID: 20720206.
Grau GE, Piguet PF, Engers HD, Louis JA, Vassalli P, Lambert PH. L3T4+ T lymphocytes play a major role in the pathogenesis of murine cerebral malaria. J Immunol. 1986;137(7):2348–54. PubMed PMID: 3093572.
Cox-Singh J, Hiu J, Lucas SB, Divis PC, Zulkarnaen M, Chandran P, et al. Severe malaria - a case of fatal Plasmodium knowlesi infection with post-mortem findings: a case report. Malar J. 2010;9:10. PubMed PMID: 20064229, Pubmed Central PMCID: 2818646.
Cox-Singh J, Singh B, Daneshvar C, Planche T, Parker-Williams J, Krishna S. Anti-inflammatory cytokines predominate in acute human Plasmodium knowlesi infections. PLoS One. 2011;6(6):e20541. PubMed PMID: 21687657, Pubmed Central PMCID: 3110641.
Fujioka H, Millet P, Maeno Y, Nakazawa S, Ito Y, Howard RJ, et al. A nonhuman primate model for human cerebral malaria: rhesus monkeys experimentally infected with Plasmodium fragile. Exp Parasitol. 1994;78(4):371–6. PubMed PMID: 7515825.
Nakano Y, Fujioka H, Luc KD, Rabbege JR, Todd GD, Collins WE, et al. A correlation of the sequestration rate of Plasmodium coatneyi-infected erythrocytes in cerebral and subcutaneous tissues of a rhesus monkey. Am J Trop Med Hyg. 1996;55(3):311–4. PubMed PMID: 8842121.
Smith CD, Brown AE, Nakazawa S, Fujioka H, Aikawa M. Multi-organ erythrocyte sequestration and ligand expression in rhesus monkeys infected with Plasmodium coatneyi malaria. Am J Trop Med Hyg. 1996;55(4):379–83. PubMed PMID: 8916792.
Kawai S, Sugiyama M. Imaging analysis of the brain in a primate model of cerebral malaria. Acta Trop. 2010;114(3):152–6. PubMed PMID: 19467218.
Moreno A, Cabrera-Mora M, Garcia A, Orkin J, Strobert E, Barnwell JW, et al. Plasmodium coatneyi in rhesus macaques replicates the multi-systemic dysfunction of severe malaria in humans. Infect Immun. 2013;81(6):1889–904. PubMed PMID: 23509137.
Tongren JE, Yang C, Collins WE, Sullivan JS, Lal AA, Xiao L. Expression of proinflammatory cytokines in four regions of the brain in Macaque mulatta (rhesus) monkeys infected with Plasmodium coatneyi. Am J Trop Med Hyg. 2000;62(4):530–4. PubMed PMID: 11220773.
Gysin J, Aikawa M, Tourneur N, Tegoshi T. Experimental Plasmodium falciparum cerebral malaria in the squirrel monkey Saimiri sciureus. Exp Parasitol. 1992;75(4):390–8. PubMed PMID: 1493871.
Robert C, Peyrol S, Pouvelle B, Gay-Andrieu F, Gysin J. Ultrastructural aspects of Plasmodium falciparum-infected erythrocyte adherence to endothelial cells of Saimiri brain microvasculature. Am J Trop Med Hyg. 1996;54(2):169–77. PubMed PMID: 8619443.
Hill AV, Allsopp CE, Kwiatkowski D, Anstey NM, Twumasi P, Rowe PA, et al. Common west African HLA antigens are associated with protection from severe malaria. Nature. 1991;352(6336):595–600. PubMed PMID: 1865923.
Bull PC, Lowe BS, Kortok M, Molyneux CS, Newbold CI, Marsh K. Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria. Nat Med. 1998;4(3):358–60. PubMed PMID: 9500614.
Gupta S, Snow RW, Donnelly CA, Marsh K, Newbold C. Immunity to non-cerebral severe malaria is acquired after one or two infections. Nat Med. 1999;5(3):340–3. PubMed PMID: 10086393.
Snow RW, Nahlen B, Palmer A, Donnelly CA, Gupta S, Marsh K. Risk of severe malaria among African infants: direct evidence of clinical protection during early infancy. J Infect Dis. 1998;177(3):819–22. PubMed PMID: 9498474.
Riley EM. Is T-cell priming required for initiation of pathology in malaria infections? Immunol Today. 1999;20(5):228–33. PubMed PMID: 10322302.
Grau GE, Piguet PF, Vassalli P, Lambert PH. Tumor-necrosis factor and other cytokines in cerebral malaria: experimental and clinical data. Immunol Rev. 1989;112:49–70. PubMed PMID: 2575074.
Kwiatkowski D, Hill AV, Sambou I, Twumasi P, Castracane J, Manogue KR, et al. TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet. 1990;336(8725):1201–4. PubMed PMID: 1978068.
Dodoo D, Omer FM, Todd J, Akanmori BD, Koram KA, Riley EM. Absolute levels and ratios of proinflammatory and anti-inflammatory cytokine production in vitro predict clinical immunity to Plasmodium falciparum malaria. J Infect Dis. 2002;185(7):971–9. PubMed PMID: 11920322.
Elhassan IM, Hviid L, Satti G, Akerstrom B, Jakobsen PH, Jensen JB, et al. Evidence of endothelial inflammation, T cell activation, and T cell reallocation in uncomplicated Plasmodium falciparum malaria. Am J Trop Med Hyg. 1994;51(3):372–9. PubMed PMID: 7524374.
Loizon S, Boeuf P, Tetteh JK, Goka B, Obeng-Adjei G, Kurtzhals JA, et al. V beta profiles in African children with acute cerebral or uncomplicated malaria: very focused changes among a remarkable global stability. Microbes Infect. 2007;9(11):1252–9. PubMed PMID: 17890120.
Artavanis-Tsakonas K, Riley EM. Innate immune response to malaria: rapid induction of IFN-gamma from human NK cells by live Plasmodium falciparum-infected erythrocytes. J Immunol. 2002;169(6):2956–63. PubMed PMID: 12218109.
Waterfall M, Black A, Riley E. Gammadelta+ T cells preferentially respond to live rather than killed malaria parasites. Infect Immun. 1998;66(5):2393–8. PubMed PMID: 9573139, Pubmed Central PMCID: 108213.
Walther M, Jeffries D, Finney OC, Njie M, Ebonyi A, Deininger S, et al. Distinct roles for FOXP3 and FOXP3 CD4 T cells in regulating cellular immunity to uncomplicated and severe Plasmodium falciparum malaria. PLoS Pathog. 2009;5(4):e1000364. PubMed PMID: 19343213, Pubmed Central PMCID: 2658808.
McGuire W, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature. 1994; 371(6497):508–10. PubMed PMID: 7935762.
Riley EM, Wahl S, Perkins DJ, Schofield L. Regulating immunity to malaria. Parasite Immunol. 2006;28(1–2):35–49. PubMed PMID: 16438675.
Sherry BA, Alava G, Tracey KJ, Martiney J, Cerami A, Slater AF. Malaria-specific metabolite hemozoin mediates the release of several potent endogenous pyrogens (TNF, MIP-1 alpha, and MIP-1 beta) in vitro, and altered thermoregulation in vivo. J Inflamm. 1995;45(2):85–96. PubMed PMID: 7583361.
Coban C, Ishii KJ, Kawai T, Hemmi H, Sato S, Uematsu S, et al. Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin. J Exp Med. 2005;201(1):19–25. PubMed PMID: 15630134, Pubmed Central PMCID: 2212757.
Deshpande P, Shastry P. Modulation of cytokine profiles by malaria pigment – hemozoin: role of IL-10 in suppression of proliferative responses of mitogen stimulated human PBMC. Cytokine. 2004;28(6):205–13. PubMed PMID: 15566949.
Schwarzer E, Turrini F, Ulliers D, Giribaldi G, Ginsburg H, Arese P. Impairment of macrophage functions after ingestion of Plasmodium falciparum-infected erythrocytes or isolated malarial pigment. J Exp Med. 1992;176(4):1033–41. PubMed PMID: 1402649, Pubmed Central PMCID: 2119406.
Rother RP, Bell L, Hillmen P, Gladwin MT. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA. 2005;293(13):1653–62. PubMed PMID: 15811985.
Lee SK, Ding JL. A perspective on the role of extracellular hemoglobin on the innate immune system. DNA Cell Biol. 2013;32(2):36–40. PubMed PMID: 23249270, Pubmed Central PMCID: 3557431.
John CC, Opika-Opoka R, Byarugaba J, Idro R, Boivin MJ. Low levels of RANTES are associated with mortality in children with cerebral malaria. J Infect Dis. 2006;194(6):837–45. PubMed PMID: 16941352.
Moxon CA, Heyderman RS, Wassmer SC. Dysregulation of coagulation in cerebral malaria. Mol Biochem Parasitol. 2009;166(2):99–108. PubMed PMID: 19450727.
Tripathi AK, Sha W, Shulaev V, Stins MF, Sullivan Jr DJ. Plasmodium falciparum-infected erythrocytes induce NF-kappaB regulated inflammatory pathways in human cerebral endothelium. Blood. 2009;114(19):4243–52. PubMed PMID: 19713460, Pubmed Central PMCID: 2925626.
de Mendonca VR, Goncalves MS, Barral-Netto M. The host genetic diversity in malaria infection. J Trop Med. 2012;2012:940616. PubMed PMID: 23316245, Pubmed Central PMCID: 3532872.
Cappadoro M, Giribaldi G, O’Brien E, Turrini F, Mannu F, Ulliers D, et al. Early phagocytosis of glucose-6-phosphate dehydrogenase (G6PD)-deficient erythrocytes parasitized by Plasmodium falciparum may explain malaria protection in G6PD deficiency. Blood. 1998;92(7):2527–34. PubMed PMID: 9746794.
Sambo MR, Trovoada MJ, Benchimol C, Quinhentos V, Goncalves L, Velosa R, et al. Transforming growth factor beta 2 and heme oxygenase 1 genes are risk factors for the cerebral malaria syndrome in Angolan children. PLoS One. 2010;5(6):e11141. PubMed PMID: 20585394, Pubmed Central PMCID: 2886838.
Takeda M, Kikuchi M, Ubalee R, Na-Bangchang K, Ruangweerayut R, Shibahara S, et al. Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to cerebral malaria in Myanmar. Jpn J Infect Dis. 2005;58(5):268–71. PubMed PMID: 16249618.
Mendonca VR, Luz NF, Santos NJ, Borges VM, Goncalves MS, Andrade BB, et al. Association between the haptoglobin and heme oxygenase 1 genetic profiles and soluble CD163 in susceptibility to and severity of human malaria. Infect Immun. 2012;80(4):1445–54. PubMed PMID: 22290142, Pubmed Central PMCID: 3318432.
Sam-Agudu NA, Greene JA, Opoka RO, Kazura JW, Boivin MJ, Zimmerman PA, et al. TLR9 polymorphisms are associated with altered IFN-gamma levels in children with cerebral malaria. Am J Trop Med Hyg. 2010;82(4):548–55. PubMed PMID: 20348497, Pubmed Central PMCID: 2844552.
Mockenhaupt FP, Cramer JP, Hamann L, Stegemann MS, Eckert J, Oh NR, et al. Toll-like receptor (TLR) polymorphisms in African children: common TLR-4 variants predispose to severe malaria. Proc Natl Acad Sci U S A. 2006;103(1):177–82. PubMed PMID: 16371473, Pubmed Central PMCID: 1324982.
Warrell DA, Looareesuwan S, Phillips RE, White NJ, Warrell MJ, Chapel HM, et al. Function of the blood-cerebrospinal fluid barrier in human cerebral malaria: rejection of the permeability hypothesis. Am J Trop Med Hyg. 1986;35(5):882–9. PubMed PMID: 2429567.
Brown H, Hien TT, Day N, Mai NT, Chuong LV, Chau TT, et al. Evidence of blood-brain barrier dysfunction in human cerebral malaria. Neuropathol Appl Neurobiol. 1999;25(4):331–40. PubMed PMID: 10476050.
Brown H, Rogerson S, Taylor T, Tembo M, Mwenechanya J, Molyneux M, et al. Blood-brain barrier function in cerebral malaria in Malawian children. Am J Trop Med Hyg. 2001;64(3–4):207–13. PubMed PMID: 11442219.
Dorovini-Zis K, Schmidt K, Huynh H, Fu W, Whitten RO, Milner D, et al. The neuropathology of fatal cerebral malaria in Malawian children. Am J Pathol. 2011;178(5):2146–58. PubMed PMID: 21514429, Pubmed Central PMCID: 3081150.
Renia L, Wu Howland S, Claser C, Charlotte Gruner A, Suwanarusk R, Hui Teo T, et al. Cerebral malaria: mysteries at the blood-brain barrier. Virulence. 2012;3(2):193–201. PubMed PMID: 22460644, Pubmed Central PMCID: 3396698.
Clark IA, Cowden WB. Roles of TNF in malaria and other parasitic infections. Immunol Ser. 1992;56:365–407. PubMed PMID: 1550869.
Wong D, Dorovini-Zis K, Vincent SR. Cytokines, nitric oxide, and cGMP modulate the permeability of an in vitro model of the human blood-brain barrier. Exp Neurol. 2004;190(2):446–55. PubMed PMID: 15530883.
Yuan SY. Signal transduction pathways in enhanced microvascular permeability. Microcirculation. 2000;7(6 Pt 1):395–403. PubMed PMID: 11142336.
Wassmer SC, Combes V, Candal FJ, Juhan-Vague I, Grau GE. Platelets potentiate brain endothelial alterations induced by Plasmodium falciparum. Infect Immun. 2006;74(1):645–53. PubMed PMID: 16369021, Pubmed Central PMCID: 1346683.
Esamai F, Ernerudh J, Janols H, Welin S, Ekerfelt C, Mining S, et al. Cerebral malaria in children: serum and cerebrospinal fluid TNF-alpha and TGF-beta levels and their relationship to clinical outcome. J Trop Pediatr. 2003;49(4):216–23. PubMed PMID: 12929882.
Wassmer SC, de Souza JB, Frere C, Candal FJ, Juhan-Vague I, Grau GE. TGF-beta1 released from activated platelets can induce TNF-stimulated human brain endothelium apoptosis: a new mechanism for microvascular lesion during cerebral malaria. J Immunol. 2006;176(2): 1180–4. PubMed PMID: 16394007.
Jambou R, Combes V, Jambou MJ, Weksler BB, Couraud PO, Grau GE. Plasmodium falciparum adhesion on human brain microvascular endothelial cells involves transmigration-like cup formation and induces opening of intercellular junctions. PLoS Pathog. 2010;6(7): e1001021. PubMed PMID: 20686652.
Pino P, Taoufiq Z, Nitcheu J, Vouldoukis I, Mazier D. Blood-brain barrier breakdown during cerebral malaria: suicide or murder? Thromb Haemost. 2005;94(2):336–40. PubMed PMID: 16113823.
Pino P, Vouldoukis I, Kolb JP, Mahmoudi N, Desportes-Livage I, Bricaire F, et al. Plasmodium falciparum – infected erythrocyte adhesion induces caspase activation and apoptosis in human endothelial cells. J Infect Dis. 2003;187(8):1283–90. PubMed PMID: 12696008.
Armulik A, Genove G, Mae M, Nisancioglu MH, Wallgard E, Niaudet C, et al. Pericytes regulate the blood-brain barrier. Nature. 2010;468(7323):557–61. PubMed PMID: 20944627.
Sa-Pereira I, Brites D, Brito MA. Neurovascular unit: a focus on pericytes. Mol Neurobiol. 2012;45(2):327–47. PubMed PMID: 22371274.
Dalkara T, Gursoy-Ozdemir Y, Yemisci M. Brain microvascular pericytes in health and disease. Acta Neuropathol. 2011;122(1):1–9. PubMed PMID: 21656168.
Kovac A, Erickson MA, Banks WA. Brain microvascular pericytes are immunoactive in culture: cytokine, chemokine, nitric oxide, and LRP-1 expression in response to lipopolysaccharide. J Neuroinflammation. 2011;8:139. PubMed PMID: 21995440, Pubmed Central PMCID: 3207972.
Medana IM, Idro R, Newton CR. Axonal and astrocyte injury markers in the cerebrospinal fluid of Kenyan children with severe malaria. J Neurol Sci. 2007;258(1–2):93–8. PubMed PMID: 17459417.
Stirling DP, Stys PK. Mechanisms of axonal injury: internodal nanocomplexes and calcium deregulation. Trends Mol Med. 2010;16(4):160–70. PubMed PMID: 20207196, Pubmed Central PMCID: 2976657.
Dolinak D, Smith C, Graham DI. Hypoglycaemia is a cause of axonal injury. Neuropathol Appl Neurobiol. 2000;26(5):448–53. PubMed PMID: 11054185.
Kaur B, Rutty GN, Timperley WR. The possible role of hypoxia in the formation of axonal bulbs. J Clin Pathol. 1999;52(3):203–9. PubMed PMID: 10450180, Pubmed Central PMCID: 501080.
Schluesener HJ, Kremsner PG, Meyermann R. Widespread expression of MRP8 and MRP14 in human cerebral malaria by microglial cells. Acta Neuropathol. 1998;96(6):575–80. PubMed PMID: 9845287.
Beattie EC, Stellwagen D, Morishita W, Bresnahan JC, Ha BK, Von Zastrow M, et al. Control of synaptic strength by glial TNFalpha. Science. 2002;295(5563):2282–5. PubMed PMID: 11910117.
Pickering M, Cumiskey D, O’Connor JJ. Actions of TNF-alpha on glutamatergic synaptic transmission in the central nervous system. Exp Physiol. 2005;90(5):663–70. PubMed PMID: 15944202.
Li N, Worthmann H, Deb M, Chen S, Weissenborn K. Nitric oxide (NO) and asymmetric dimethylarginine (ADMA): their pathophysiological role and involvement in intracerebral hemorrhage. Neurol Res. 2011;33(5):541–8. PubMed PMID: 21669125.
Weiss G, Thuma PE, Biemba G, Mabeza G, Werner ER, Gordeuk VR. Cerebrospinal fluid levels of biopterin, nitric oxide metabolites, and immune activation markers and the clinical course of human cerebral malaria. J Infect Dis. 1998;177(4):1064–8. PubMed PMID: 9534983.
Agbenyega T, Angus B, Bedu-Addo G, Baffoe-Bonnie B, Griffin G, Vallance P, et al. Plasma nitrogen oxides and blood lactate concentrations in Ghanaian children with malaria. Trans R Soc Trop Med Hyg. 1997;91(3):298–302. PubMed PMID: 9231201.
Clark IA, Awburn MM, Whitten RO, Harper CG, Liomba NG, Molyneux ME, et al. Tissue distribution of migration inhibitory factor and inducible nitric oxide synthase in falciparum malaria and sepsis in African children. Malar J. 2003;2:6. PubMed PMID: 12716455, Pubmed Central PMCID: 154094.
Wolf A, Zalpour C, Theilmeier G, Wang BY, Ma A, Anderson B, et al. Dietary L-arginine supplementation normalizes platelet aggregation in hypercholesterolemic humans. J Am Coll Cardiol. 1997;29(3):479–85. PubMed PMID: 9060881.
Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A. 1991;88(11):4651–5. PubMed PMID: 1675786, Pubmed Central PMCID: 51723.
Garthwaite J. Concepts of neural nitric oxide-mediated transmission. Eur J Neurosci. 2008;27(11):2783–802. PubMed PMID: 18588525, Pubmed Central PMCID: 2610389.
Guix FX, Uribesalgo I, Coma M, Munoz FJ. The physiology and pathophysiology of nitric oxide in the brain. Prog Neurobiol. 2005;76(2):126–52. PubMed PMID: 16115721.
Contestabile A. Role of nitric oxide in cerebellar development and function: focus on granule neurons. Cerebellum. 2012;11(1):50–61. PubMed PMID: 21104176.
Yeo TW, Lampah DA, Gitawati R, Tjitra E, Kenangalem E, McNeil YR, et al. Impaired nitric oxide bioavailability and L-arginine reversible endothelial dysfunction in adults with falciparum malaria. J Exp Med. 2007;204(11):2693–704. PubMed PMID: 17954570, Pubmed Central PMCID: 2118490.
Yeo TW, Lampah DA, Gitawati R, Tjitra E, Kenangalem E, McNeil YR, et al. Recovery of endothelial function in severe falciparum malaria: relationship with improvement in plasma L-arginine and blood lactate concentrations. J Infect Dis. 2008;198(4):602–8. PubMed PMID: 18605903, Pubmed Central PMCID: 2709993.
Yeo TW, Lampah DA, Gitawati R, Tjitra E, Kenangalem E, Piera K, et al. Angiopoietin-2 is associated with decreased endothelial nitric oxide and poor clinical outcome in severe falciparum malaria. Proc Natl Acad Sci U S A. 2008;105(44):17097–102. PubMed PMID: 18957536.
Hawkes M, Opoka RO, Namasopo S, Miller C, Thorpe KE, Lavery JV, et al. Inhaled nitric oxide for the adjunctive therapy of severe malaria: protocol for a randomized controlled trial. Trials. 2011;12:176. PubMed PMID: 21752262, Pubmed Central PMCID: 3151218.
Higgins SJ, Kain KC, Liles WC. Immunopathogenesis of falciparum malaria: implications for adjunctive therapy in the management of severe and cerebral malaria. Expert Rev Anti Infect Ther. 2011;9(9):803–19. PubMed PMID: 21905788.
Gramaglia I, Sobolewski P, Meays D, Contreras R, Nolan JP, Frangos JA, et al. Low nitric oxide bioavailability contributes to the genesis of experimental cerebral malaria. Nat Med. 2006;12(12):1417–22. PubMed PMID: 17099710.
Ferroni P, Vazzana N, Riondino S, Cuccurullo C, Guadagni F, Davi G. Platelet function in health and disease: from molecular mechanisms, redox considerations to novel therapeutic opportunities. Antioxid Redox Signal. 2012;17(10):1447–85. PubMed PMID: 22458931.
Bernassola F, Rossi A, Melino G. Regulation of transglutaminases by nitric oxide. Ann N Y Acad Sci. 1999;887:83–91. PubMed PMID: 10668466.
Zhou Z, Yee DL, Guchhait P. Molecular link between intravascular hemolysis and vascular occlusion in sickle cell disease. Curr Vasc Pharmacol. 2012;10(6):756–61. PubMed PMID: 22272904.
Buhrer C, Felderhoff-Mueser U, Wellmann S. Erythropoietin and ischemic conditioning – why two good things may be bad. Acta Paediatr. 2007;96(6):787–9. PubMed PMID: 17537001.
Kaiser K, Texier A, Ferrandiz J, Buguet A, Meiller A, Latour C, et al. Recombinant human erythropoietin prevents the death of mice during cerebral malaria. J Infect Dis. 2006;193(7):987–95. PubMed PMID: 16518761.
Wiese L, Hempel C, Penkowa M, Kirkby N, Kurtzhals JA. Recombinant human erythropoietin increases survival and reduces neuronal apoptosis in a murine model of cerebral malaria. Malar J. 2008;7:3. PubMed PMID: 18179698.
Casals-Pascual C, Idro R, Gicheru N, Gwer S, Kitsao B, Gitau E, et al. High levels of erythropoietin are associated with protection against neurological sequelae in African children with cerebral malaria. Proc Natl Acad Sci U S A. 2008;105(7):2634–9. PubMed PMID: 18263734.
Medana IM, Day NP, Hien TT, White NJ, Turner GD. Erythropoietin and its receptors in the brainstem of adults with fatal falciparum malaria. Malar J. 2009;8:261. PubMed PMID: 19930602, Pubmed Central PMCID: 2785829.
Ehrenreich H, Weissenborn K, Prange H, Schneider D, Weimar C, Wartenberg K, et al. Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke. 2009;40(12):e647–56. PubMed PMID: 19834012.
Picot S, Bienvenu AL, Konate S, Sissoko S, Barry A, Diarra E, et al. Safety of epoietin beta-quinine drug combination in children with cerebral malaria in Mali. Malar J. 2009;8:169. PubMed PMID: 19630971, Pubmed Central PMCID: 2723129.
Najjar SS, Rao SV, Melloni C, Raman SV, Povsic TJ, Melton L, et al. Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial. JAMA. 2011;305(18):1863–72. PubMed PMID: 21558517, Pubmed Central PMCID: 3486644.
Lapchak PA. Erythropoietin molecules to treat acute ischemic stroke: a translational dilemma! Expert Opin Investig Drugs. 2010;19(10):1179–86. PubMed PMID: 20828227, Pubmed Central PMCID: 2947745.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Park, G.S., John, C.C. (2014). Cerebral Malaria. In: Peterson, P., Toborek, M. (eds) Neuroinflammation and Neurodegeneration. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1071-7_19
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1071-7_19
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-1070-0
Online ISBN: 978-1-4939-1071-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)